{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:35:07Z","timestamp":1788388507845,"version":"build-2803163510"},"reference-count":18,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,4,8]]},"DOI":"10.2967\/jnumed.124.269064","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:23:33Z","timestamp":1746055413000},"page":"jnumed.124.269064","source":"Crossref","is-referenced-by-count":2,"title":["A Phase I\/II Study of [\n                    <sup>177<\/sup>\n                    Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol"],"prefix":"10.2967","author":[{"given":"Sara","family":"Harsini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Saprunoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Bloise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"2025043020232678000_jnumed.124.269064v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2025043020232678000_jnumed.124.269064v1.2","doi-asserted-by":"publisher","DOI":"10.1159\/000519861"},{"key":"2025043020232678000_jnumed.124.269064v1.3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41391-023-00725-8","article-title":"Real-world treatment patterns and overall survival among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population","volume":"27","author":"Freedland","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2025043020232678000_jnumed.124.269064v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025043020232678000_jnumed.124.269064v1.5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1470-2045(23)00529-6","article-title":"Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial","volume":"25","author":"Hofman","year":"2024","journal-title":"Lancet Oncol."},{"key":"2025043020232678000_jnumed.124.269064v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2025043020232678000_jnumed.124.269064v1.7","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.7150\/thno.87663","article-title":"Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands","volume":"13","author":"Kuo","year":"2023","journal-title":"Theranostics."},{"key":"2025043020232678000_jnumed.124.269064v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2025043020232678000_jnumed.124.269064v1.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.100123"},{"key":"2025043020232678000_jnumed.124.269064v1.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1422-4"},{"key":"2025043020232678000_jnumed.124.269064v1.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.159012"},{"key":"2025043020232678000_jnumed.124.269064v1.12","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands","volume":"49","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025043020232678000_jnumed.124.269064v1.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2025043020232678000_jnumed.124.269064v1.14","doi-asserted-by":"publisher","DOI":"10.1021\/bc200279b"},{"key":"2025043020232678000_jnumed.124.269064v1.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1357"},{"key":"2025043020232678000_jnumed.124.269064v1.16","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1021\/acs.molpharmaceut.8b00499","article-title":"Effects of linker modification on tumor-to-kidney contrast of 68Ga-labeled PSMA-targeted imaging probes","volume":"15","author":"Kuo","year":"2018","journal-title":"Mol Pharm."},{"key":"2025043020232678000_jnumed.124.269064v1.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.250738"},{"key":"2025043020232678000_jnumed.124.269064v1.18","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.7150\/thno.76571","article-title":"What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake","volume":"12","author":"Kuo","year":"2022","journal-title":"Theranostics."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.269064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:23:35Z","timestamp":1746055415000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.269064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":18,"alternative-id":["10.2967\/jnumed.124.269064"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.269064","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}